_id
6915f5debc934aba376b23a7
Ticker
SDZNY
Name
Sandoz Group AG
Exchange
OTCGREY
Address
Centralbahnstrasse 4, Basel, Switzerland, 4051
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.sandoz.com
Description
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Last Close
72.72
Volume
1213
Current Price
75.53
Change
-0.58
Last Updated
2026-01-06T10:56:42.706Z
Image
-
Ipo Date
-
Market Cap
32371152896
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9475000000000001
Sentiment Sources
6
Rating
3
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
430701660
Income Tax Expense
63000000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
3314000000
Inventories
2513000000
Total Current Assets
7072000000
Property Plant Equipment
1576000000
Total Assets
-
Payables
1435000000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
9008000000
Equity
-
Bs_currency_symbol
USD
Depreciation
126000000
Change In Working Capital
-
Cash From Operations
42500000
Capital Expenditures
77500000
Cash From Investing
-93500000
Cash From Financing
81000000
Net Change In Cash
26500000
Cf_currency_symbol
USD
PE
139.3846
PB
-
ROE
-
ROA
-
FCF
-35000000
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
2.5
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
63000000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3314000000
Quarters > 0 > balance Sheet > inventories
2513000000
Quarters > 0 > balance Sheet > total Current Assets
7072000000
Quarters > 0 > balance Sheet > property Plant Equipment
1576000000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
1435000000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9008000000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
117500000
Quarters > 0 > cash Flow > depreciation
126000000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
42500000
Quarters > 0 > cash Flow > capital Expenditures
77500000
Quarters > 0 > cash Flow > cash From Investing
-93500000
Quarters > 0 > cash Flow > cash From Financing
81000000
Quarters > 0 > cash Flow > net Change In Cash
26500000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-35000000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
63000000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
3314000000
Quarters > 1 > balance Sheet > inventories
2513000000
Quarters > 1 > balance Sheet > total Current Assets
7072000000
Quarters > 1 > balance Sheet > property Plant Equipment
1576000000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
1435000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9008000000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
117500000
Quarters > 1 > cash Flow > depreciation
126000000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
42500000
Quarters > 1 > cash Flow > capital Expenditures
77500000
Quarters > 1 > cash Flow > cash From Investing
-93500000
Quarters > 1 > cash Flow > cash From Financing
81000000
Quarters > 1 > cash Flow > net Change In Cash
26500000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-35000000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2022-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
81000000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
235000000
Quarters > 2 > cash Flow > depreciation
119500000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
171000000
Quarters > 2 > cash Flow > capital Expenditures
62500000
Quarters > 2 > cash Flow > cash From Investing
-87500000
Quarters > 2 > cash Flow > cash From Financing
-76000000
Quarters > 2 > cash Flow > net Change In Cash
15500000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
108500000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2022-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
81000000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
235000000
Quarters > 3 > cash Flow > depreciation
119500000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
171000000
Quarters > 3 > cash Flow > capital Expenditures
62500000
Quarters > 3 > cash Flow > cash From Investing
-87500000
Quarters > 3 > cash Flow > cash From Financing
-76000000
Quarters > 3 > cash Flow > net Change In Cash
15500000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
108500000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10384000000
Annuals > 0 > income Statement > cost Of Revenue
5458000000
Annuals > 0 > income Statement > gross Profit
4926000000
Annuals > 0 > income Statement > operating Expenses
10077000000
Annuals > 0 > income Statement > operating Income
307000000
Annuals > 0 > income Statement > interest Expense
251000000
Annuals > 0 > income Statement > pretax Income
-11000000
Annuals > 0 > income Statement > net Income
0
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-215000000
Annuals > 0 > income Statement > shares Outstanding
430701660
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
2.956471494607088
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1191000000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2205000000
Annuals > 0 > balance Sheet > inventories
2800000000
Annuals > 0 > balance Sheet > total Current Assets
7801000000
Annuals > 0 > balance Sheet > property Plant Equipment
1988000000
Annuals > 0 > balance Sheet > total Assets
19907000000
Annuals > 0 > balance Sheet > payables
1519000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
4390000000
Annuals > 0 > balance Sheet > total Liabilities
11743000000
Annuals > 0 > balance Sheet > equity
8163000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
0
Annuals > 0 > cash Flow > depreciation
502000000
Annuals > 0 > cash Flow > change In Working Capital
-365000000
Annuals > 0 > cash Flow > cash From Operations
656000000
Annuals > 0 > cash Flow > capital Expenditures
596000000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
82000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0
Annuals > 0 > ratios > PB
3.8210724264608604
Annuals > 0 > ratios > ROE
0
Annuals > 0 > ratios > ROA
0
Annuals > 0 > ratios > FCF
60000000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.005778120184899846
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
9979000000
Annuals > 1 > income Statement > cost Of Revenue
5415000000
Annuals > 1 > income Statement > gross Profit
4564000000
Annuals > 1 > income Statement > operating Expenses
9604000000
Annuals > 1 > income Statement > operating Income
375000000
Annuals > 1 > income Statement > interest Expense
202000000
Annuals > 1 > income Statement > pretax Income
130000000
Annuals > 1 > income Statement > net Income
77000000
Annuals > 1 > income Statement > eps
0.17909923718006382
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
429929246
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
3.757891572301834
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1109000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2615000000
Annuals > 1 > balance Sheet > inventories
2700000000
Annuals > 1 > balance Sheet > total Current Assets
7572000000
Annuals > 1 > balance Sheet > property Plant Equipment
1850000000
Annuals > 1 > balance Sheet > total Assets
19430000000
Annuals > 1 > balance Sheet > payables
1593000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
3975000000
Annuals > 1 > balance Sheet > total Liabilities
10776000000
Annuals > 1 > balance Sheet > equity
8645000000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
77000000
Annuals > 1 > cash Flow > depreciation
525000000
Annuals > 1 > cash Flow > change In Working Capital
-663000000
Annuals > 1 > cash Flow > cash From Operations
362000000
Annuals > 1 > cash Flow > capital Expenditures
625000000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
1035000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.17909923718006382
Annuals > 1 > ratios > PB
3.6015588195858883
Annuals > 1 > ratios > ROE
0.8906882591093117
Annuals > 1 > ratios > ROA
0.39629439011837364
Annuals > 1 > ratios > FCF
-263000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.026355346227076863
Annuals > 1 > health Score
36
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
9306000000
Annuals > 2 > income Statement > cost Of Revenue
4928000000
Annuals > 2 > income Statement > gross Profit
4378000000
Annuals > 2 > income Statement > operating Expenses
22500
Annuals > 2 > income Statement > operating Income
-22500
Annuals > 2 > income Statement > interest Expense
89000000
Annuals > 2 > income Statement > pretax Income
-22500
Annuals > 2 > income Statement > net Income
-22861
Annuals > 2 > income Statement > eps
-0.000053041763341067286
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
431000000
Annuals > 2 > income Statement > income Tax Expense
252000000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-0.000241779497098646
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
100000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2207000000
Annuals > 2 > balance Sheet > inventories
2124000000
Annuals > 2 > balance Sheet > total Current Assets
5976000000
Annuals > 2 > balance Sheet > property Plant Equipment
1904000000
Annuals > 2 > balance Sheet > total Assets
100000
Annuals > 2 > balance Sheet > payables
1357000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
30000000
Annuals > 2 > balance Sheet > total Liabilities
22861
Annuals > 2 > balance Sheet > equity
77139
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
848000000
Annuals > 2 > cash Flow > depreciation
458000000
Annuals > 2 > cash Flow > change In Working Capital
-36000000
Annuals > 2 > cash Flow > cash From Operations
1223000000
Annuals > 2 > cash Flow > capital Expenditures
278000000
Annuals > 2 > cash Flow > cash From Investing
-430000000
Annuals > 2 > cash Flow > cash From Financing
-769000000
Annuals > 2 > cash Flow > net Change In Cash
34000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.000053041763341067286
Annuals > 2 > ratios > PB
404633.453894917
Annuals > 2 > ratios > ROE
-29.63611143520139
Annuals > 2 > ratios > ROA
-22.861
Annuals > 2 > ratios > FCF
945000000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.10154738878143134
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
403000000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3395000000
Annuals > 3 > balance Sheet > inventories
2006000000
Annuals > 3 > balance Sheet > total Current Assets
5565000000
Annuals > 3 > balance Sheet > property Plant Equipment
1933000000
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
1173000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8365000000
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
908000000
Annuals > 3 > cash Flow > depreciation
489000000
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
1354000000
Annuals > 3 > cash Flow > capital Expenditures
313000000
Annuals > 3 > cash Flow > cash From Investing
-691000000
Annuals > 3 > cash Flow > cash From Financing
-657000000
Annuals > 3 > cash Flow > net Change In Cash
1000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
1041000000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
46
Valuation > metrics > PE
139.3846
Valuation > final Score
20
Valuation > verdict
457.5% Overvalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.92822299651568
Liquidity > metrics > Quick Ratio
3.1770034843205575
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:32:35.664Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-03
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASandoz Group (OTCMKTS:SDZNY) Reaches New 1-Year High - Should You Buy? MarketBeat
Read more →Sandoz Group (OTCMKTS:SDZNY) Sees Unusually-High Trading Volume - Should You Buy? - MarketBeat
1/16/2026
Sandoz Group (OTCMKTS:SDZNY) Sees Unusually-High Trading Volume - Should You Buy? MarketBeat
Read more →Showing 2 of 10
(Last Updated 2023-06-30)
Rating:
HOLD
$
Analyst Picks
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2023-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of Sandoz Group AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.